Dr Albiges on immunotherapy in renal cell carcinoma
Laurence Albiges, MD, medical oncologist and head of the Genitourinary [...]
Nivolumab approved for use by the NHS in England and Wales for people with advanced renal cell carcinoma
Nivolumab (Opdivo) has been recommended by the National Institute for [...]
Proposed changes to NICE appraisal process to enable faster access to cost-effective treatments
The National Institute for Health and Care Excellence (NICE) and [...]
UK cancer cases to increase to half a million in the next 20 years
A Cancer Research UK (CRUK) study published in the British [...]
Tracon Pharmaceuticals present results from phase 1b trial of TCR105 plus axitinib in kidney cancer
TRACON Pharmaceuticals presented final results from a phase 1b clinical trial combining [...]
Cabozantinib superior to sunitinib as a first-line therapy for advanced kidney cancer
Results from the phase II CABOSUN clinical trial, showing cabozantinib [...]
Sutent shown to improve disease-free survival in people with kidney cancer
Results from the S-TRAC study were presented at the European [...]
New ‘Ofsted-style’ ratings for NHS cancer care across England
NHS England has published new 'Ofsted-style' ratings for cancer care in [...]
Phase I study shows promise with nivolumab and ipilimumab combination in kidney cancer
Results from the CheckMate-016 study to investigate a combination of [...]
Exelixis announces phase 1 trial results of cabozantinib plus nivolumab in advanced genitourinary tumours
Exelixis today announced results from a phase 1 trial of [...]
